Skip to content

Medipan GmbH

German independent family-owned diagnostics company specializing in autoimmune and infectious disease in vitro diagnostics, known for the AKLIDES® automated immunofluorescence system.

Last updated September 29, 2026

AI crawler reads

No AI crawler has read this profile since Oct 28, 2026.

Overview

Medipan GmbH is a German medical diagnostics company founded in 1992 and headquartered in Blankenfelde-Mahlow OT Dahlewitz, south of Berlin. It is an independent family company active in in vitro diagnostics (IVD), particularly immunological techniques for the diagnosis of autoimmune diseases. Together with its sister company GA Generic Assays GmbH, Medipan develops and supplies test kits and automated laboratory systems for laboratories, clinics, research centers, and physicians worldwide, operating in over 70 countries. The company began by marketing radioimmunoassay (RIA) products for thyroid function, disease, and tumor markers, initially in Germany and soon internationally. Its portfolio later expanded to non-radioactive tests and assays for autoantibodies found in autoimmune type 1 diabetes. Today Medipan offers a broad range of diagnostic methods including Immunofluorescence Assays (IFA), LINE & Dot Immunoblot Assays, ELISA, Radioimmunoassay (RIA), and rapid tests, covering indications such as thyroid disorders, diabetes, rheumatoid arthritis, gastrointestinal diseases, and neurological conditions. A key milestone came in 2009 when Medipan became the first company in the world to introduce a commercially available system for fully automated, objective evaluation of cell-based immunofluorescence tests: the AKLIDES® system. This innovation enabled standardization and mathematically proven prediction of antibody concentration, earning several awards. Medipan continues to position itself as an innovative partner for medical laboratories and research centers, with a focus on digital immunological techniques for fast and accurate autoimmune diagnosis.

History

Medipan GmbH was founded in 1992 as an independent family company active in medical diagnostics, with a focus on immunological techniques for the diagnosis of autoimmune diseases. The company is located at Ludwig-Erhard-Ring 3, 15827 Blankenfelde-Mahlow OT Dahlewitz, south of Berlin. It began by marketing radioimmunoassay (RIA) products for the characterization of thyroid function, disease, and tumor markers, working with partners from nuclear medicine laboratories, initially within Germany and soon from other countries. Over time, the product portfolio expanded to include non-radioactive tests and tests to detect autoantibodies found in patients suffering from autoimmune type 1 diabetes. In 2009, Medipan became the first company in the world to introduce a commercially available system for the fully automated, objective evaluation of cell-based immunofluorescence tests: the AKLIDES® system. This marked a new milestone in the development of the immunofluorescence method, one of the oldest and most widespread laboratory procedures for the diagnosis of autoimmune diseases. The system enabled standardization and mathematically proven prediction of antibody concentration, and received several awards. Today, together with its sister company GA Generic Assays GmbH, Medipan is active in over 70 countries and is an innovative and world-renowned partner for medical laboratories, physicians, medical institutes, and research centers in the manufacture of manual detection test kits and automated systems. The company continues to grow in domestic and international diagnostic markets, offering a broad portfolio of assays based on advanced immunological methods such as Immunofluorescence Assays (IFA), LINE & Dot Immunoblot Assays, ELISA, and Radioimmunoassay (RIA).

  • 2009

    First company worldwide to introduce a commercially available system for fully automated, objective evaluation of cell-based immunofluorescence tests: the AKLIDES® system.

  • 1992

    Medipan GmbH founded as an independent family company in Blankenfelde-Mahlow, Germany.

Products and positioning

Innovative in vitro diagnostics partner for autoimmune and infectious diseases, offering high-quality manual and automated solutions for laboratories worldwide.

  • AKLIDES® system

    Fully automated, objective evaluation system for cell-based immunofluorescence tests, introduced in 2009.

  • CytoBead® ANCA

    Assay for ANCA detection.

  • Anti-Phospholipid 10 Dot

    Dot assay for anti-phospholipid antibodies.

  • Anti-MuSK IFA

    Immunofluorescence assay for anti-MuSK antibodies.

  • Medizym® T.R.A. human

    Assay for thyroid receptor antibodies.

  • SELco® TSH rapid

    Radioimmunoassay for quantitative determination of Thyrotropin (TSH) in human serum.

  • CentAK® anti-GAD 65 M

    Radioimmunoassay for quantitative determination of antibodies against Glutamic Acid Decarboxylase (GAD65) in human serum.

Sources5 sources

Cite this profile: Cite the canonical profile. /brand-wiki/medipan-gmbh · Editorial policy · How profiles are compiled